Figure 5 presents the mutation rates of GAS2 (1.3%), GAS2L1 (1.2%), GAS2L2 (2.4%) and GAS2L3 (1.3%) in the whole tumour samples. This evidence concerns the gene GAS2L1 and neoplasm.